生命科学资讯

In the clinic for Feb. 10, 2026

Appointments and advancements for Feb. 10, 2026

Financings for Feb. 10, 2026

Regulatory actions for Feb. 10, 2026

Holiday notice

Appointments and advancements for Feb. 9, 2026

Financings for Feb. 9, 2026

In the clinic for Feb. 9, 2026

Other news to note for Feb. 9, 2026

Regulatory actions for Feb. 9, 2026

Innovent-Lilly $8.5B deal signals new China inflection point

Biggest gainers and losers for Feb. 2-6, 2026

Venenum Biodesign discloses new MOGAT2 inhibitors

Korean researchers report new HER1/HER2 mutant inhibitors

Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists

Idorsia gets FDA-backed route to approval for oral Fabry drug

More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M

Bayer’s asundexian cuts stroke risk 26% in phase III win

Money raised by biopharma

Biopharma money raised: Jan. 1-Feb. 5, 2026